Michael Edward Manna Buys 2,000 Shares of Ultralife (NASDAQ:ULBI) Stock

Ultralife Corporation (NASDAQ:ULBI) CEO Michael Edward Manna acquired 2,000 shares of the business’s stock in a transaction that occurred on Thursday, March 12th. The stock was acquired at an average price of $6.01 per share, for a total transaction of $12,020.00. Following the completion of the acquisition, the chief executive officer directly owned 26,874 shares of the company’s stock, valued at $161,512.74. This trade represents a 8.04% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this link.

Ultralife Price Performance

Shares of ULBI stock opened at $6.93 on Wednesday. The firm’s 50 day moving average price is $6.19 and its two-hundred day moving average price is $6.28. The company has a debt-to-equity ratio of 0.34, a quick ratio of 1.42 and a current ratio of 2.99. Ultralife Corporation has a 52-week low of $4.07 and a 52-week high of $9.52. The stock has a market cap of $115.38 million, a PE ratio of -19.25 and a beta of 0.88.

Ultralife (NASDAQ:ULBI) last issued its earnings results on Tuesday, March 10th. The technology company reported $0.12 EPS for the quarter, missing the consensus estimate of $0.24 by ($0.12). The business had revenue of $48.48 million for the quarter, compared to the consensus estimate of $57.00 million. Ultralife had a negative net margin of 3.09% and a positive return on equity of 3.06%.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of ULBI. Empowered Funds LLC bought a new stake in Ultralife in the fourth quarter valued at approximately $44,000. Lazard Asset Management LLC boosted its position in shares of Ultralife by 1,650.0% during the second quarter. Lazard Asset Management LLC now owns 5,565 shares of the technology company’s stock worth $49,000 after purchasing an additional 5,247 shares in the last quarter. Prelude Capital Management LLC acquired a new position in shares of Ultralife in the 3rd quarter valued at $71,000. Jane Street Group LLC acquired a new position in shares of Ultralife in the 4th quarter valued at $75,000. Finally, Jones Financial Companies Lllp increased its position in shares of Ultralife by 1,428.7% in the 1st quarter. Jones Financial Companies Lllp now owns 15,287 shares of the technology company’s stock valued at $82,000 after buying an additional 14,287 shares in the last quarter. Institutional investors and hedge funds own 30.68% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reiterated a “sell (d+)” rating on shares of Ultralife in a report on Monday, December 29th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company has an average rating of “Sell”.

Ultralife Company Profile

Ultralife Corporation (NASDAQ: ULBI) develops, manufactures and sells a broad range of energy and communications products for defense, medical, automotive and consumer electronics markets. The company operates through two primary segments: Power Systems and Communications Systems. In its Power Systems segment, Ultralife produces lithium-ion rechargeable cells and battery packs, primary lithium batteries, alkaline and rechargeable battery packs, chargers and battery accessories designed to meet demanding performance and safety requirements.